You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSI-high Endometrial Cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

Not yet recruiting
  • Endometrial Carcinoma
  • Tumor Molecular Features Screening Model
  • open surgery
  • laparoscopic surgery
  • (no location specified)
Jun 7, 2023

Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy,

Active, not recruiting
Has Results
  • Endometrial Cancer
  • +2 more
  • Vaginal Cuff Brachytherapy
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 13, 2021

Localized Resectable Tumor, MSI/dMMR or EBV-positive Gastric Cancers Trial in France (Pembrolizumab)

Recruiting
  • Localized Resectable Tumor
  • MSI/dMMR or EBV-positive Gastric Cancers
  • Lyon, France
  • +6 more
Apr 28, 2022

Colorectal Tumors Trial in China (Pembrolizumab, Oxaliplatin, Leucovorin)

Recruiting
  • Colorectal Neoplasms
  • Pembrolizumab
  • +6 more
  • Beijing, Beijing, China
  • +21 more
Jan 25, 2023

Endometrial Cancer Trial in United Kingdom (BMN 673)

Withdrawn
  • Endometrial Cancer
  • BMN 673
  • Brighton, East Sussex, United Kingdom
  • +15 more
Aug 5, 2021

Endometrial Cancer Trial in Marywood (Carboplatin and Paclitaxel, Radiation Therapy)

Recruiting
  • Endometrial Cancer
  • Carboplatin and Paclitaxel
  • Radiation Therapy
  • Marywood, Illinois
    Loyola University Medical Center
Sep 7, 2021

Patients With Early Stage Endometrial Cancer

Not yet recruiting
  • Endometrium Cancer
  • Positron emission tomography and computed tomography
  • Surgical treatment
  • (no location specified)
Sep 28, 2021

Medical Imaging in Gynecological Cancer (PRODIGYN)

Not yet recruiting
  • Cervix Cancer
  • +2 more
  • FDG-PET/CT and FDG-PET/MRI
  • (no location specified)
May 2, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

MSI-H Solid Malignant Tumor Trial in China (HLX10)

Recruiting
  • MSI-H Solid Malignant Tumor
  • Hefei, Anhui, China
  • +32 more
Oct 26, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Circulating Tumor DNA Study in Patients With Endometrial Cancer

Recruiting
  • Endometrial Cancer
  • Whole blood
  • Paris, France
    Hôpital Cochin
Jul 12, 2023

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting
  • Uterine Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +7 more
Apr 4, 2022

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Endometrial Carcinoma Trial in France (Pre-operative SN mapping with radionucleide, Intra-operative SN mapping with patent V

Active, not recruiting
  • Endometrial Carcinoma
  • Pre-operative SN mapping with radionucleide
  • +4 more
  • Avignon, France
  • +15 more
Dec 13, 2021

Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)

Recruiting
  • Colorectal Cancer
  • Pembrolizumab
  • +4 more
  • Orange City, Florida
  • +54 more
Aug 17, 2022

Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

Active, not recruiting
  • Advanced Solid Tumor
  • +3 more
  • TP-1454 monotherapy
  • TP-1454 combination therapy
  • Phoenix, Arizona
  • +8 more
Nov 18, 2022

Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,

Terminated
  • Endometrial Adenocarcinoma
  • +8 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Perioperative Immunotherapy in MSI-H Gastrointestinal Tumors

Not yet recruiting
  • To Evaluate the Safety and Effectiveness of Immunotherapy During the Perioperative Treatment Stage in MSI-H Gastrointestinal Cancer
  • No interventions
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 26, 2020

Recurrence for High Risk Endometrial Cancer Patients

Completed
  • High-risk Endometrial Cancer
  • adjuvant therapy
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Dec 7, 2020

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting
  • Endometrial Cancer
  • Anchorage, Alaska
  • +78 more
Jul 25, 2022

Colorectal Cancer Trial in Beijing (Fruquintinib and Sintilimab)

Recruiting
  • Colorectal Cancer
  • Fruquintinib and Sintilimab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences
Jan 5, 2021

Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

Recruiting
  • Metastatic Breast Carcinoma
  • +13 more
  • 68GaNOTA-Anti-HER2 VHH1
  • Brussels, Brussel, Belgium
    Uz Brussel
Dec 17, 2021